Preview Mode Links will not work in preview mode

Clinical Summaries presented by InpharmD™

May 17, 2021

A randomized, multicenter, international, double-blind, placebo-controlled trial conducted to determine whether the addition of midodrine to standard care reduces the time to discontinuation of IV vasopressor use in otherwise resuscitated patients